October 23, 2016 10:13 PM ET


Company Overview of Verdezyne, Inc.

Company Overview

Verdezyne, Inc. operates as an industrial biotechnology company. It creates bio-based processes that offer clean and sustainable fuels and chemicals. The company designs and engineers enzymes, metabolic pathways, and microorganisms that produce target chemicals. Verdezyne, Inc. was formerly known as CODA Genomics, Inc. and changed its name to Verdezyne, Inc. in Novemeber 2008. Verdezyne, Inc. was founded in 2005 and is based in Carlsbad, California.

2715 Loker Avenue West

Carlsbad, CA 92010

United States

Founded in 2005





Key Executives for Verdezyne, Inc.

Chief Executive Officer and President
Chief Financial Officer
Age: 65
Senior Vice President of Intellectual Property and General Counsel
Vice President of Development
Principal Biologist
Compensation as of Fiscal Year 2016.

Verdezyne, Inc. Key Developments

Verdezyne Sing Distribution Agreement with Aceto

Verdezyne announced the launch of an agreement for sales and distribution of its BIOLON DDDA (biobased dodecanedioic acid). The company has signed the agreement with Aceto. As part of the agreement, BIOLON DDDA will be produced by Verdezyne and will be distributed in the US of America by Aceto.

Verdezyne, Inc. Appoints David Kelsey as Chief Financial Officer Replacing Brian Conn

Verdezyne, Inc. has appointed David Kelsey as Chief Financial Officer (CFO). He brings a deep leadership background with a number of established companies, both public and private. Kelsey was CFO of Elevance Renewable Sciences from 2011 to 2015. Kelsey serves as a director and chair of the audit committee of Granite Construction, Inc. Kelsey replaces Brian Conn, who left the company in February of this year.

Verdezyne, Inc. Signs Distribution Agreement with Connell Bros. Co. LLC

Verdezyne, Inc. and Connell Bros. Co. LLC announced an agreement for sales and distribution of Verdezyne’s BIOLON™ DDDA (biobased dodecanedioic acid or “DC12”). BIOLON™ DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia and will be distributed in 17 countries throughout Asia-Pacific, including China, Japan and South Korea. The agreement assures CBC of access to more than 10% of the expected plant capacity. Verdezyne’s BIOLON™ DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make a variety of end-user products including automotive parts, toothbrush bristles, cosmetics, and fragrances. Verdezyne’s plant, expected to be completed in 2017, is anticipated to have the capacity to produce up to 9,000 metric tons of diacids including BIOLON™ DDDA annually.

Similar Private Companies By Industry

Company Name Region
10x Technology LLC United States
20/20 Custom Molded Plastics,Ltd. United States
21st Century Plastics Corporation United States
2N2, Inc. United States
6062 Holdings, LLC United States

Recent Private Companies Transactions

Private Placement
December 11, 2015

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Verdezyne, Inc., please visit www.verdezyne.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.